Hologram distraction to reduce pain, anxiety, and fear during burn dressing in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children aged 3–12 with second-degree burns covering less than 10% of body surface who are undergoing their first dressing change will be exposed to a three-dimensional holographic fan display during the procedure. The hologram device creates floating 3D images using LED lights on high-speed rotating blades to capture the child’s attention. Pain, anxiety, fear, and vital signs will be measured before, during, and after dressing to determine whether the hologram alters these responses. The protocol focuses on non-pharmacological distraction as an adjunct to routine burn dressing care in a pediatric hospital setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The subject has indicated their willingness to participate in the study. Physical and mental health.
* The age range of the subjects included in this study was from 3 to 12 years of age.
* The subject had never previously engaged in the practice of dressing a burn.
* The presence of only second degree burns
* Burn percentage is under 10%

Exclusion Criteria:

* The subject is unwilling or unable to provide informed consent or assent (if applicable).
* The subject has a history of significant physical or mental health disorders that may interfere with participation in the study.
* The subject is younger than 3 years old or older than 12 years old.
* The subject has previously engaged in the practice of burn dressing or similar procedures.
* The presence of burns other than second-degree burns (e.g., first-degree or third-degree burns).
* The percentage of burn area is greater than 10%.

Where it's running

• Erzurum Provincial Health Directorate Erzurum City Hospital
  Erzurum, Yakutiye, Turkey (Türkiye) Recruiting
• Erzurum Provincial Health Directorate Erzurum City Hospital
  Erzurum, Yakutiye, Turkey (Türkiye) Not yet recruiting

Study contacts

• Study coordinator: Zeynep KARAMAN ÖZLÜ, PhD
• Email: zynp_krmnzl@hotmail.com
• Phone: +905434628682

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of inspiratory muscle training after burn injury

  This study tests whether inspiratory muscle training helps people who have had burn injuries and inhalation damage improve breathing and physical function.

  Recruiting Cairo University · Giza · NCT07867639

• Human umbilical cord mesenchymal stem cells with bovine type I collagen for third-degree burn wounds

  This will test whether human umbilical cord mesenchymal stem cells combined with bovine type I collagen are safe and tolerable for adults with small third-degree burn wounds.

  Recruiting Phase 1/2 The First Affiliated Hospital of Xinxiang Medical College · Xinxiang, Henan · NCT07530003

• Blue light to speed healing of donor-site wounds after skin grafts

  This study will try adding blue light therapy to usual care to see if donor-site wounds heal faster and with less pain or infection in adults with intermediate-to-deep burns who need skin grafts.

  Recruiting AUSL Romagna Rimini · Cesena, Forlì-Cesena · NCT07453927

• VR-enhanced progressive muscle relaxation for chronic symptoms after burn injury

  This will try progressive muscle relaxation with and without virtual reality to see if it helps adult burn survivors reduce chronic pain, itch, anxiety, sleep problems, or fatigue.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07317271

• Lateral, Anterior, Medial (LAM) femoral cutaneous block for thigh donor-site pain

  This tries to see if a LAM nerve block can numb the anterolateral thigh and reduce donor-site pain without weakening leg muscles in adults having split-thickness skin grafts.

  Recruiting University of Washington · Seattle, Washington · NCT07221903

• KJ101 for debridement of deep second-degree burns

  This trial will test whether topical KJ101 helps remove dead tissue and promote healing in adults with deep second-degree burns compared with chymotrypsin and placebo.

  Recruiting Phase 2 Shanghai Bao Pharmaceuticals Co., Ltd. · Shanghai, Shanghai Municipality · NCT07025408

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.